Oragenics, Inc (OGEN) Stock Price

0.49 ▼ -0.01 (-2.00%)
Open: 0.52 Vol: 11.8K Day's range: 0.48 - 0.52 Sep 25, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
OGEN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.51▼ 0.51▼ 0.51▼ 0.50▼ 0.50▼
MA10 0.50▼ 0.50▼ 0.50▼ 0.50▼ 0.51▼
MA20 0.51▼ 0.51▼ 0.51▼ 0.51▼ 0.55▼
MA50 0.52▼ 0.53▼ 0.53▼ 0.52▼ 0.73▼
MA100 0.56▼ 0.56▼ 0.56▼ 0.56▼ 0.80▼
MA200 0.59▼ 0.60▼ 0.60▼ 0.66▼ 2.06▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.002▲ 0.002▲ 0.002▲ 0.000▲ 0.007▲
RSI 43.861▼ 43.681▼ 43.683▼ 44.371▼ 37.969▼
STOCH 66.030     63.618     63.618     41.667     17.133▼
WILL %R -62.750     -62.750     -62.750     -80.000▼ -92.308▼
CCI -53.904     -71.742     -71.742     -51.256     -87.486    
Latest Filters Detected On OGEN
MA $OGEN Price Crossed Below MA(7) Set Alert
▲ GAP $OGEN Open Gap Up %3 Set Alert
▲ GAP $OGEN Open Gap Up %2 Set Alert
Oragenics, Inc News
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Activates All Australian Phase IIa Trial Sites for ONP-002
Tuesday, July 07, 2026 03:25 AM
Oragenics (NYSE American: OGEN) announced that all three sites in its Australian Phase IIa clinical trial of ONP-002 for mild traumatic brain injury (concussion) are now active and enrolling ...
Biomednewsbreaks - Oragenics Inc. (NYSE American: OGEN) Activates All Australian Phase Iia Trial Sites For ONP-002
Monday, July 06, 2026 07:06 PM
(MENAFN- Investor Brand Network) Oragenics (NYSE American: OGEN) announced that all three sites in its Australian Phase IIa clinical trial of ONP-002 for mild traumatic brain injury (concussion) are ...
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Reports Early Dosing Progress in Phase IIa Trial of Intranasal Concussion Therapy
Monday, April 20, 2026 06:20 AM
Oragenics (NYSE American: OGEN) announced that two patients have been enrolled and eight doses administered in its ongoing Phase IIa clinical trial evaluating ONP-002, its lead candidate for the ...
OGEN historical stock data
date open high low close volume
25/09/26 0.52 0.52 0.48 0.49 11,800
24/09/26 0.49 0.50 0.49 0.50 17,400
23/09/26 0.52 0.53 0.49 0.49 40,000
21/09/26 0.48 0.52 0.48 0.52 37,900
18/09/26 0.50 0.52 0.48 0.48 43,000
17/09/26 0.508 0.508 0.508 0.508 42,124
16/09/26 0.50 0.52 0.48 0.50 54,500
14/09/26 0.48 0.50 0.48 0.50 23,500
11/09/26 0.50 0.50 0.48 0.48 66,900
10/09/26 0.51 0.51 0.50 0.50 9,200
Quote Details
52wk Low:0.48
52wk High:1.45
Vol:11.8K
Avg Vol(3m):572.2K
1Y Chng:-64.75%
1M Chng:-8.63%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 2.18M